Lupin informs about press release

10 May 2019 Evaluate

Lupin has informed about submission of a press release as regards launch of Clobazam Tablets, 10 mg and 20 mg, being the generic version of Lundbeck Pharms, LLC's Onfi Tablets, 10 mg and 20 mg, indicated for the adjunctive treatment of seizures, for which, US FDA approval was received earlier. This may be considered as a disclosure pursuant to Regulation 30 of the SEW (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2098.25 -40.40 (-1.89%)
02-Feb-2026 10:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.25
Dr. Reddys Lab 1181.55
Cipla 1302.00
Zydus Lifesciences 871.10
Lupin 2098.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×